GlassScriptPhysician profile
Paul W Wasserstein
NPI 1467560094
$416.69
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $74.61 · 2024: $38.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $161.06 | 2019 | |
| Daiichi Sankyo INC. | $42.73 | 2019-2024 | Enhertu |
| Foundation Medicine, INC. | $33.55 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.99 | 2019 | |
| Pfizer INC. | $24.19 | 2024 | |
| Agios Pharmaceuticals, INC. | $22.74 | 2020 | |
| Exelixis INC. | $20.77 | 2019 | |
| Merck Sharp & Dohme LLC | $19.55 | 2019 | |
| Lilly USA, LLC | $18.75 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.32 | 2020 | |
| Rigel Pharmaceuticals, INC. | $17.43 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Wasserstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.